Sera Prognostics
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 57
- Market Cap
- -
- Introduction
Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.
Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs
- Conditions
- Preterm BirthPreterm Labor
- Interventions
- Other: Multimodal intervention strategy
- First Posted Date
- 2020-03-10
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Sera Prognostics, Inc.
- Target Recruit Count
- 6500
- Registration Number
- NCT04301518
- Locations
- 🇺🇸
UCSD, San Diego, California, United States
🇺🇸Yale, New Haven, Connecticut, United States
🇺🇸Delaware/Christiana Care, Newark, Delaware, United States
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
- Conditions
- Preterm Birth
- First Posted Date
- 2016-06-01
- Last Posted Date
- 2021-04-14
- Lead Sponsor
- Sera Prognostics, Inc.
- Target Recruit Count
- 5011
- Registration Number
- NCT02787213
- Locations
- 🇺🇸
University of California, Irvine Medical Center, Orange, California, United States
🇺🇸Ochsner Baptist Medical Center, New Orleans, Louisiana, United States
🇺🇸University of Colorado-Denver, Aurora, Colorado, United States
Proteomic Assessment of Preterm Birth
- Conditions
- Preterm Birth
- First Posted Date
- 2011-06-10
- Last Posted Date
- 2015-06-11
- Lead Sponsor
- Sera Prognostics, Inc.
- Target Recruit Count
- 5500
- Registration Number
- NCT01371019
- Locations
- 🇺🇸
Christiana Care Health System, Newark, Delaware, United States
🇺🇸University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
🇺🇸Oregon Health and Science University, Portland, Oregon, United States